Alnylam Pharmaceuticals, Inc. vs PPG Industries, Inc. — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $288 (market cap $39.89B), while PPG Industries, Inc. trades at $113.55 (market cap $26.03B). The key difference: Alnylam Pharmaceuticals, Inc. is the larger of the two by market cap, and PPG Industries, Inc. pays a 2.43% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | PPG | |
|---|---|---|
Market Cap | $39.89B | $26.03B |
Sector | Health | Basic Materials |
52-Week High | $491.22 | $131.56 |
52-Week Low | $278.09 | $94.34 |
Enterprise Value | $38.15B | $32.13B |
Dividend Yield | — | 2.43% |
Trailing returns across standard periods
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →